MedPath

Nutritional Improvement in Chronic Heart Failure Patients

Not Applicable
Completed
Conditions
Heart Failure
Interventions
Other: standard treatment
Dietary Supplement: Hypercaloric beverages
Other: educational structured counseling
Registration Number
NCT02599935
Lead Sponsor
Luis Guerra
Brief Summary

To assess the effect over the nutritional status in patients who are malnourished with chronic heart failure, of an educational intervention and the provision of nutritional supplements. Randomized clinical trial with blind assessors. Unicentric. Follow up: 12 months

Detailed Description

Randomized clinical trial with blinded evaluators. (The evaluators will not know the group the patients are assigned. Blinded evaluators are no responsible for randomization and intervention once the patients have been randomized). Patients will be recruited from the cardiology inpatient unit of tertiary hospital, before discharge. Patients will be divided in two groups randomly:

In one arm will be held a double intervention:

* A structured educational intervention oriented to the patient and primary caregiver, with respect to dietary habits, highly energetic and healthy food, the frequency and manner of eating, exercise and programming breaks.

* supplementation with dietary supplements, distinguishing one type of product or another, depending on whether the subject to study: diabetes and or kidney failure.

In the other arm of the study was carried out regular interventions

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
76
Inclusion Criteria
  • adult patients with the diagnosis of heart failure: who inadvertently lost at least 5% of their "dry weight" in the last six months and / or moderately or severely malnourished according to the GSA and / or at risk or malnourished according to Mini Nutritional Assessment.
  • Willing to participate by accepting and signing an informed consent.
  • On treatment with inhibitors of angiotensin converting enzyme (ACE) inhibitors and / or antagonists of angiotensin II receptors (ARBs) and / or beta blockers.
Exclusion Criteria
  • Concurrent active cancer diagnosed.
  • Previous history Dementia or severe cognitive impairment.
  • Participation in another clinical trial simultaneously.
  • Social or health condition that makes the patient impossible to follow the treatment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
usual interventionsstandard treatmentUsual treatment without nutritional supplements or structured assessment
educational intervention and supplementsHypercaloric beveragesstructured educational intervention and dietary supplements
educational intervention and supplementseducational structured counselingstructured educational intervention and dietary supplements
Primary Outcome Measures
NameTimeMethod
Change on nutritional status measured with Global Subjective AssesmentAt inclusion , months 3 and 9
Secondary Outcome Measures
NameTimeMethod
Number of readmission.at month 12
Change on quality of life of patients measured with Minnesota Living With Heart Failure Questionnaire, after an educational intervention and nutritional supplementAt inclusion , months 3 and 9
Change on meters walked in six minutes (functional capacity), after the interventionAt inclusion , months 3 and 9

Trial Locations

Locations (1)

Servicio de Nefrología Hospital General universitario Gregorio Maranon

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath